Clinical trials
Phase 4 COVID-19 trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 27 |
| 2021 | 15 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Terminated | 7 |
| Active, not recruiting | 7 |
| Withdrawn | 4 |
| Recruiting | 4 |
| Unknown status | 4 |
| Not yet recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ModernaTX, Inc. | 4 |
| Duke University | 2 |
| Emory University | 2 |
| Frederick Health | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Novavax | 2 |
| Sharp HealthCare | 2 |
| St. Francis Hospital, New York | 2 |
| BioNTech SE | 1 |
| Britt Skaathun | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 58 |
| Coronavirus Infections | 19 |
| Virus Diseases | 4 |
| Influenza, Human | 3 |
| Respiratory Tract Infections | 3 |
| Severe Acute Respiratory Syndrome | 3 |
| Coronaviridae Infections | 2 |
| Infections | 2 |
| Nidovirales Infections | 2 |
| Pathologic Complete Response | 2 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.